Transfusion for remote damage control resuscitation
The Solstrand Remote Damage Control Resuscitation Symposium
Remote damage control resuscitation and the Solstrand Conference: defining the need, the language, and a way forward
Practical translation of hemorrhage control techniques to the civilian trauma scene
Pathogenesis of acute traumatic coagulopathy
Coagulopathy after traumatic brain injury: incidence, pathogenesis, and treatment options
The microcirculation: linking trauma and coagulopathy
Prehospital detection of traumatic coagulopathy
Near infrared spectroscopy: clinical and research uses
The development and feasibility of a remote damage control resuscitation prehospital plasma transfusion protocol for warfarin reversal for patients with traumatic brain injury
The evolving role of lyophilized plasma in remote damage control resuscitation in the French Armed Forces Health Service
The use of lyophilized plasma in a severe multi-injury pig model
Spray-dried plasma and fresh frozen plasma modulate permeability and inflammation in vitro in vascular endothelial cells
The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding
Tranexamic acid in remote damage control resuscitation
Thrombosomes: a platelet-derived hemostatic agent for control of noncompressible hemorrhage
Fresh whole blood use by forward surgical teams in Afghanistan is associated with improved survival compared to component therapy without platelets
Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma
Blood Far Forward—a whole blood research and training program for austere environments
Development of a riboflavin and ultraviolet light-based device to treat whole blood
Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time